Under construction – not a live service
Sign in
Not yet taking people in IndonesiaNo phase

Tests a data-driven action model to help Indonesian district health leaders

Tests a data-based decision model for primary care in Indonesian districts.

Key facts

Who runs it
Oxford University Clinical Research Unit Indonesia
Where
Gerung and Purbalingga, IndonesiaSee the 2 sites
Trial code
Registry title
Scalable Public Health Empowerment, Research, and Education Sites (SPHERES)
Status
Not yet recruiting
People taking part
1,750,000 people, planned
Started
14 Aug 2025
Expected to end
31 Mar 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Prescription for Action (SPHERES Model)
Record updated
15 August 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people who live in the district areas and use the health services of the taking-part health facilities. Health workers and district health officials who agree to data collection can also join.

Sex
All sexes can join.

Main reasons for not taking part

  • People who decline to give informed consent
  • People not directly involved in or using services of the health facilities or district health offices
  • Health workers or district health officials who cannot give consent because of cognitive impairment or acute illness

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Residing in or participating in the district catchment areas
  • Receiving services from participating health care facilities
  • Health providers and district health officials consent to participate in data collection

Who cannot take part

  • Inability to provide consent due to cognitive impairment or acute illness for health workers or district health officials involved in data collection
  • Individuals (health workers or patients) who decline to provide informed consent
  • Individuals who are not directly involved in or accessing services from health care facilities or district health offices

Where in Indonesia

  • West Lombok District Health OfficeGerung, IndonesiaContact: Zulkipli Zulkipli, Ns, MMNo longer taking part
  • Purbalingga District Health OfficePurbalingga, IndonesiaContact: Jusi Febrianto, MD, MPHNo longer taking part

About the trial

What the trial wants to find out

SPHERES is a health service research trial in the Indonesian primary care system designed to improve health system performance using a structured data-driven action model. The intervention empowers district health leaders to make data-informed decisions that will enhance outcomes across maternal, child, infectious, and non-communicable disease programs.

The 2 groups in the trial

  • SPHERES Intervention ArmTreatment being tested

    Participants (district populations) receive services improved by the SPHERES model, which includes structured prescription-for-action protocols targeting three priority domains (infectious disease, maternal \& child health, and non-communicable diseases).

    Treatment: Prescription for Action (SPHERES Model)

  • ControlNo study treatment, for comparison

    Standard of care are expected at primary health centers before the SPHERES intervention is deployed

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
End-to-end Digital Transformation for Primary Health Care Performance Management Via Scalable Public Health Empowerment, Research, and Education Sites: A Stepped-Wedge Cluster Randomized Trial
Plain-language title
Tests a data-driven action model to help Indonesian district health leadersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
15 August 2025